(Q53255017)

12 May 2018

title

Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy. (English)

1 reference

12 May 2018

1 reference

Kavitha Ramasamy Reddy

1

1 reference

12 May 2018

Yongli Guan

2

1 reference

12 May 2018

Guoting Qin

3

1 reference

12 May 2018

Zhou Zhou

4

1 reference

12 May 2018

Naijie Jing

5

1 reference

12 May 2018

publication date

7 April 2011

1 reference

12 May 2018

published in

The Prostate

1 reference

12 May 2018

volume

71

1 reference

12 May 2018

issue

16

1 reference

12 May 2018

page(s)

1796-1809

1 reference

12 May 2018

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Stats: transcriptional control and biological impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Three-dimensional structure of the Stat3beta homodimer bound to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Regulation of angiogenesis by hypoxia-inducible factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Vascular endothelial growth factor (VEGF) signaling in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Computational study on mechanism of G-quartet oligonucleotide T40214 selectively targeting Stat3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

G-rich oligonucleotides inhibit HIF-1alpha and HIF-2alpha and block tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Structure-activity of tetrad-forming oligonucleotides as a potent anti-HIV therapeutic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Potassium-dependent folding: a key to intracellular delivery of G-quartet oligonucleotides as HIV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Rational drug design of G-quartet DNA as anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Highly conserved amino-acid sequence between murine STAT3 and a revised human STAT3 sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Is anticancer drug development heading in the right direction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

More is less -- combining targeted therapies in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Employing tumor hypoxia for oncolytic therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21397

21 January 2018

Identifiers

DOI

10.1002/PROS.21397

1 reference

12 May 2018

release_vdcwichzrzfsvjyv4adpashn3m

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vdcwichzrzfsvjyv4adpashn3m

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

21480310

1 reference

12 May 2018